InspireMD Inc. (NSPR) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to InspireMD's second quarter 2025 earnings conference call. Currently, all participants are in a listen-only mode. We will be soliciting a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Marissa Baich from Gil Martin Group for introductory disclosures. Thank you for joining us for the InspireMD second quarter 2025 conference call. Joining us today from InspireMD are Marvin Clausman, Chief Executive Officer, and Mike Lawless, Chief Financial Officer. During this call, management will be making forward-looking statements, not historical facts, which are based upon management's current expectations, beliefs, and projections, many of which, by their nature, are inherently uncertain. These forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those expressed in such forward-looking statements. For more information about these risks please refer to the risk factors described in InspireMD's most recently filed periodic reports on Form 10-K and Form 10-Q or any other updates in our current reports on Form 8-K filed with the U.S. Securities and Exchange Commission and InspireMD's press release that accompanies this call, particularly the cautionary statements made in it. This call contains time-sensitive information that is accurate only as of today August 5, 2025. Except as required by law, InspireMD disclaims any obligation to publicly update or revise any information to reflect events or circumstances that occur after this call. It is now my pleasure to turn the call over to Marvin Slausman, Chief Executive Officer. Marvin, please go ahead. Marvin Slausman Thank you, and...